Abstract
Dosage imbalance for chromosome 21 in Down syndrome and mutations in the amyloid precursor protein (APP) and presenilin-1 (PS-1 ) genes in early-onset familial Alzheimer's disease (FAD) result in elevated production and deposition of amyloid-β (Aβ) peptides1, particularly the 42 amino acid form, Aβ1–42. One difficulty in studying the generation and deposition of Aβ, neuritic abnormalities, synaptic dysfunction, neuronal cell death and dementia that occurs in Alzheimer's disease (AD) is the paucity of small animal models. To examine effects of the FAD mutations in vivo, we transferred yeast artificial chromosomes (YACs) containing the entire genomic copy of human APP and/or PS-1 genes harboring FAD mutations into transgenic mice2,3. We now document that a mutant APP YAC transgenic mouse develops Aβ deposits and that this deposition is accelerated when the animals are mated to homozygosity and/or to mutant PS-1 YAC transgenic mice.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Selkoe, D. J. Trends Cell Biol. 8, 447–453 (1998).
Lamb, B. T. et al. Hum. Mol. Genet. 6, 1535– 1541 (1997).
Lamb, B. T. et al. Nat. Genet. 5, 22– 30 (1993).
Price, D. L. & Sisodia, S. S. Annu. Rev. Neurosci. 21, 479–505 (1998).
Alzheimer's Disease Collaborative Group. Nat. Genet. 11, 219–222 ( 1995).
Rogaev, E. I. et al. Genomics 40, 415–424 (1997).
Klafki, H. W., Wiltfang, J. & Staufenbiel, M. Anal. Biochem. 237, 24– 29 (1996).
Wiltfang, J. et al. Electrophoresis 18, 527– 532 (1997).
Citron, M. et al. Nat. Med. 3, 67–72 (1996).
Duff, K. et al. Nature 383, 710–713 (1996).
Borchelt, D. R. et al. Neuron 17, 1005–1013 (1996).
Scheuner, D. et al. Nat. Med. 2, 864–870 (1996).
Lemere, C. A. et al. Nat. Med. 2, 1146– 1150 (1996).
Prasher, V. P. et al. Ann. Neurol. 43, 380– 383 (1998).
Borchelt, D. R. et al. Neuron 19, 939–945 (1997).
Acknowledgements
This work was supported by National Institutes of Health Grants AG14451 and AG08012 (B.T.L.), T32 GM08613 (E.J.H.), and AG14248 (S.S.S.), the American Health Assistance Foundation (S.S.S.) and the Bristol-Meyers Squibb Pharmaceutical Research Institute (S.L.W.).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lamb, B., Bardel, K., Kulnane, L. et al. Amyloid production and deposition in mutant amyloid precursor protein and presenilin-1 yeast artificial chromosome transgenic mice. Nat Neurosci 2, 695–697 (1999). https://doi.org/10.1038/11154
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/11154
This article is cited by
-
Critical thinking of Alzheimer’s transgenic mouse model: current research and future perspective
Science China Life Sciences (2023)
-
Genetic quality: a complex issue for experimental study reproducibility
Transgenic Research (2022)
-
The novel squamosamide derivative FLZ enhances BDNF/TrkB/CREB signaling and inhibits neuronal apoptosis in APP/PS1 mice
Acta Pharmacologica Sinica (2010)
-
Presenilin transgenic mice as models of Alzheimer’s disease
Brain Structure and Function (2010)
-
The value of incomplete mouse models of Alzheimer’s disease
European Journal of Nuclear Medicine and Molecular Imaging (2008)